Prediction of the biological activity spectra of organic compounds using the pass online web resource

Chemistry of Heterocyclic Compounds

Volumn 50, Issue 3, 2014, Pages 444-457

  Filimonov, D A ^a   Lagunin, A A ^a   Gloriozova, T A ^a   Rudik, A V ^a   Druzhilovskii, D S ^a   Pogodin, P V ^a,b   Poroikov, V V ^a,b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Biological activity; Computer prediction; Organic compounds; PASS Online; Pharmacologically active compounds; Web resource

Indexed keywords

EID: 84904325452     PISSN: 00093122     EISSN: 15738353     Source Type: Journal    
DOI: 10.1007/s10593-014-1496-1     Document Type: Article

References (71)

1. http://www.chemnavigator.com/cnc/products/iRL.asp
2. L. Ruddigkeit, L. C. Blum, and J.-L. Reymond, J. Chem. Inf. MoDel., 53, 56 (2013
3. Thomson Reuters IntegritySM, http://integrity.thomson-pharma.com
4. A. L. Hopkins, Nat. Chem. Biol., 4, 682 (2008
5. R. Morphy and Z. Rankovic, J. Med. Chem., 49, 4961 (2006
6. I. M. Kapetanovic, Chem.-Biol. Interact., 171, 165 (2008
7. C. G. Wermuth (editor), The Practice of Medicinal Chemistry, Third Edition, AcaDemic Press, San Diego (2008
8. C. Hansch, Acc. Chem. Res., 26, 147 (1993
9. R. Franke, Theoretical Drug Design Methods, AkaDemie-Verlag, Berlin (1984), p. 382
10. V. V. Avidon, Khim.-Farm. Zh., 8, 22 (1974
11. V. V. Avidon and V. S. Arolovich, Nauchno-Tekhnicheskaya Informatsiya, Ser. 2, No. 5, 26 (1975
12. V. V. Avidon, V. S. Arolovich, V. G. Blinova, S. P. Kozlova, and A. M. Freidina, Khim.-Farm. Zh., 17, 321 (1983
13. V. V. Avidon, V. S. Arolovich, S. P. Kozlova, and L. A. Piruzyan, Khim.-Farm. Zh., 12, No. 5, 88 (1978
14. V. V. Avidon, V. S. Arolovich, S. P. Kozlova, and L. A. Piruzyan, Khim.-Farm. Zh., 12, No. 6, 99 (1978
15. V. E. GolenDer and A. B. Rozenblit, Avtomatika i Telemekhanika, 11, 99 (1974
16. V. E. GolenDer and A. B. Rozenblit, Computer Methods for Drug Design [in Russian], Zinatne, Riga (1978
17. V. E. GolenDer and A. B. Rozenblit, Zh. Vses. Khim. Obshch. Im. D. I. MenDeleeva, 25, No. 1, 28 (1980
18. A. B. Rozenblit and V. E. GolenDer, Logic-combinatorial Methods in Drug Design [in Russian], Zinatne, Riga (1984
19. L. A. Piruzyan, V. V. Avidon, A. B. Rozenblit, V. S. Arolovich, V. E. GolenDer, S. P. Kozlova, E. M. Mikhailovskii, and E. G. Gavrishchuk, Khim.-Farm. Zh., 11, 35 (1977
20. V. V. Avidon, I. A. Pomerantsev, V. E. GolenDer, and A. B. Rozenblit, J. Chem. Inf. Comput. Sci., 22, 207 (1982
21. V. V. Avidon and L. A. Leksina, Nauchno-Tekhnicheskaya Informatsiya, Ser. 2, No. 3, 22 (1975
22. N. Veretennikova, A. Skorova, V. Kudryashova, A. Rozenblit, A. Barkans, Ya. Betinsh, V. Drboglav, L. Gitlina, Ya. Grinfelds, P. Mellis, D. Petersone, and V. Shatokhin, in: F. Chen and G. Schüürmann (editors), Quantitative Structure-Activity Relationships in Environmental Sciences, SETAC, Pensacola (1997), p. 115
23. G. M. Barenboim, L. A. Piruzyan, and A. G. Malenkov, Vestn. Akad. Nauk SSSR, No. 2, 50 (1977
24. L. A. Piruzyan, A. G. Malenkov, and G. M. Barenboim, Chemical Aspects of Human Activities and Nature Conservation [in Russian], Preprint, OtDel. Inst. Khim. Fiz. Akad. Nauk SSSR, Chernogolovka (1979
25. G. M. Barenboim and A. G. Malenkov, Biologically Active Compounds. New Search Principles [in Russian], Nauka, Moscow (1986
26. Yu. V. Burov, L. V. Korol'chenko, and V. V. Poroikov, Byull. Vses. Nauchn. Tsentra po Bezopasnosti Biologicheski Aktivnykh Veshchestv, No. 1, 4 (1990
27. V. V. Poroikov, D. A. Filimonov, and A. P. Budunova, Nauchno- tekhnicheskaya Informatsiya, Ser. 2, No. 6, 11 (1993
28. D. A. Filimonov, V. V. Poroikov, E. I. Karaicheva, R. K. Kazaryan, A. P. Budunova, E. M. Mikhailovskii, A. V. Rudnitskikh, L. V. Goncharenko, and Y. V. Burov, Eksperimental'naya i Klinicheskaya Farmakologiya, 58, No. 2, 56 (1995
29. D. A. Filimonov and V. V. Poroikov, in: M. G. Ford, R. Greenwood, G. T. Brooks, and R. Franke (editors), Bioactive Compound Design: Possibilities for Industrial Use, BIOS Scientific Publishers, Oxford (1996), p. 47
30. T. A. Gloriozova, D. A. Filimonov, A. A. Lagunin, and V. V. Poroikov, Khim.-farm. Zh., 32, No. 12, 33 (1998
31. A. V. Stepanchikova, A. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Curr. Med. Chem., 10, 225 (2003
32. D. A. Filimonov and V. V. Poroikov, Ros. Khim. Zh., L, No. 2, 66 (2006
33. D. A. Filimonov and V. V. Poroikov, in: A. Varnek and A. Tropsha (editors), Chemoinformatics Approaches to Virtual Screening, RSC Publishing, Cambridge (2008), p. 182
34. D. A. Filimonov, V. V. Poroikov, T. A. Gloriozova, and A. A. Lagunin, Certificate for the Official Registration of the PASS Computer Program No. 2006613275, September 15, 2006 [in Russian], FeDeral Service for Intellectual Property, Patents, and TraDemarks, Moscow
35. D. Filimonov, V. Poroikov, Yu. Borodina, and T. Gloriozova, J. Chem. Inf. Comput. Sci., 39, 666 (1999
36. V. V. Poroikov, D. A. Filimonov, Y. V. Borodina, A. A. Lagunin, and A. Kos, J. Chem. Inf. Comput. Sci., 40, 1349 (2000
37. V. A. Trapkov, A. P. Budunova, O. A. Burova, D. A. Filimonov, and V. V. Poroikov, Voprosy Med. Khim., 43, 39 (1997
38. A. Geronikaki, V. Poroikov, D. Hadjipavlou-Litina, D. Filimonov, A. Lagunin, and R. Mgonzo, Quant. Struct.-Act. Relat., 18, 16 (1999
39. V. V. Poroikov, D. A. Filimonov, W.-D. Ihlenfeldt, T. A. Gloriozova, A. A. Lagunin, Y. V. Borodina, A.V. Stepanchikova, and M. C. Nicklaus, J. Chem. Inf. Comput. Sci., 43, 228 (2003
40. A. Geronikaki, J. DearDen, D. Filimonov, I. Galaeva, T. Garibova, T. Gloriozova, V. Krajneva, A. Lagunin, F. Macaev, G. Molodavkin, V. Poroikov, S. Pogrebnoi, F. Shepeli, T. Voronina, M. Tsitlakidou, and L. Vlad, J. Med. Chem., 47, 2870 (2004
41. A. Geronikaki, S. Vasilevsky, D. Hadjipavlou-Litina, A. Lagunin, and V. Poroikov, Khim. Geterotsikl. Soedin., 769 (2006). [Chem. Heterocycl. Compd., 42, 675 (2006)]
42. A. A. Lagunin, O. A. Gomazkov, D. A. Filimonov, T. A. Gureeva, E. A. Dilakyan, E. V. Kugaevskaya, Y. E. Elisseeva, N. I. Solovyeva, and V. V. Poroikov, J. Med. Chem., 46, 3326 (2003
43. A. A. Geronikaki, A. A. Lagunin, D. I. Hadjipavlou-Litina, P. T. Elefteriou, D. A. Filimonov, V. V. Poroikov, I. Alam, and A. K. Saxena, J. Med. Chem., 51, 1601 (2008
44. V. Poroikov, D. Akimov, E. Shabelnikova, and D. Filimonov, SAR QSAR Environ. Res., 12, 327 (2001
45. S. A. Kryzhanovskii, R. M. Salimov, A. A. Lagunin, D. A. Filimonov, T. A. Gloriozova, and V. V. Poroikov, Khim.-farm. Zh., 45, No. 10, 25 (2011
46. V. Poroikov, D. Filimonov, A. Lagunin, T. Gloriozova, and A. Zakharov, SAR QSAR Environ. Res., 18, 101 (2007
47. S. M. IVanov, A. A. Lagunin, A. V. Zakharov, D. A. Filimonov, and V. V. Poroikov, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 7, 40 (2013
48. A. Dalby, J. G. Nourse, W. D. Hounshell, A. K. I. Gushurst, D. L. Grier, B. A. Leland, and J. Laufer, J. Chem. Inf. Comput. Sci., 32, 244 (1992
49. A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, Bioinformatics, 16, 747 (2000
50. A. V. Sadym, A. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Khim.-farm. Zh., 36, No. 10, 21 (2002
51. A. Sadym, A. Lagunin, D. Filimonov, and V. Poroikov, SAR QSAR Environ. Res., 14, 339 (2003
52. A. Geronikaki, D. Druzhilovsky, A. Zakharov, and V. Poroikov, SAR QSAR Environ. Res., 19, 27 (2008
53. PASS Online, http://www.way2drug.com/passonline
54. D. Weininger, J. Chem. Inf. Comput. Sci., 28, 31 (1988
55. http://www.chemaxon.com
56. http://www.chemspiDer.com/.
57. http://bioinformatics.charite.De/superpred/
58. http://cpi.bio-x.cn/drar/
59. D. Filimonov, A. Lagunin, A. Rudik, D. Druzhilovsky, S. IVanov, P. Pogodin, and V. Poroikov, in: Abstracts of the 19th European Symposium on Quantitative Structure-Activity Relationships, Vienna, Austria, August 26-30, 2012, p. 60
60. C. B-Rao, A. Kulkarni-Almeida, K. V. Katkar, S. Khanna, U. Ghosh, A. Keche, P. Shah, A. Srivastava, V. KorDe, K. V. S. Nemmani, N. J. Deshmukh, A. Dixit, M. K. Brahma, U. Bahirat, L. Doshi, R. Sharma, and H. Sivaramakrishnan, Bioorg. Med. Chem., 20, 2930 (2012
61. D. Verbanac, S. C. Jain, N. Jain, M. Chand, H. Čipč ić Paljetak, M. Matija?ić, M. Perić, V. Stepanić, and L. Saso, Bioorg. Med. Chem., 20, 3180 (2012
62. A. Kumar, P. Lohan, D. K. Aneja, G. K. Gupta, D. Kaushik, and O. Prakash, Eur. J. Med. Chem., 50, 81 (2012
63. I. Shcherbakova, Khim. Geterotsikl. Soedin., 6 (2013). [Chem. Heterocycl. Compd., 49, 2 (2013)]
64. http://www.cerep.fr
65. http://www.kinomescan.com
66. P. Eleftheriou, A. Geronikaki, D. Hadjipavlou-Litina, P. Vicini, O. Filz, D. Filimonov, V. Poroikov, S. S. Chaudhaery, K. K. Roy, and A. Saxena, Eur. J. Med. Chem., 47, 111 (2012
67. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Curr. Pharm. Des., 16, 1703 (2010
68. J. Frearson and P. Wyatt, Expert Opin. Drug Discovery, 5, 909 (2010
69. W. RhoDes, J. Transl. Med., 10 (Suppl. 2), A42 (2012
70. D. M. Huryn, L. O. Resnick, and P. Wipf, J. Med. Chem., 56, 7161 (2013
71. S. Ekins and B. A. Bunin, in: S. Cortagere (editor), In Silico MoDels for Drug Discovery, Series: Methods in Molecular Biology, Vol. 993, Humana Press, New York (2013), p. 139.